Both the pitavastatin molecule and the lactone metabolite undergo very little metabolism by CYP3A4 and, therefore, unlike some other statins, does not interact with CYP3A4 substrates. Pitavastatin ...

The work is a secondary analysis of the Phase III Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), which demonstrated that the cholesterol-lowering medication pitavastatin reduced ...

[13] In clinical studies, pitavastatin consistently produces a marked and sustained increase in HDL-C concentrations. Indeed, pitavastatin's ability to elevate HDL-C levels is one factor ...